- 专利标题： NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
-
申请号： EP20172206.3申请日： 2015-12-16
-
公开(公告)号： EP3715357A1公开(公告)日： 2020-09-30
- 发明人: WEINSCHENK, Toni , MAHR, Andrea , FRITSCHE, Jens , MÜLLER, Phillip , WIEBE, Anita , MISSEL, Sarah
- 申请人： Immatics Biotechnologies GmbH
- 申请人地址： Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 专利权人： Immatics Biotechnologies GmbH
- 当前专利权人： Immatics Biotechnologies GmbH
- 当前专利权人地址： Paul-Ehrlich-Strasse 15 72076 Tübingen DE
- 代理机构： Michalski Hüttermann & Partner Patentanwälte mbB
- 优先权： GB201423016 20141223; US201462096165P 20141223; GB201501017 20150121
- 主分类号： C07K7/08
- IPC分类号： C07K7/08 ; A61K38/04 ; A61K39/00 ; A61P35/00
摘要：
The current invention relates to a pharmaceutical composition comprising a peptide of the sequence according to SEQ ID No. 303 together with at least one suitable carrier and/or excipient for use in the treatment of Hepatocellular carcinoma cancer (HCC).
公开/授权文献
信息查询
